Erding

Germany

4 total trials

Filter these 4 trials by phase, condition, sponsor and more.

Open in Search →

1L LUSPA VS ESA IN NTD LOW-RISK MDS PATIENTS Ended recruitment

2022-500430-29-00 5 2023-10-11 Myelodysplastic Syndrome (MDS)
A Phase 1b/2 Study of BMS-986158 Monotherapy and Combination with either Ruxolitinib or Fedratinib in Intermediate or High Risk Myelofibrosi … Ended recruitment

2023-509635-89-00 9 2021-06-01 DIPSS-Intermediate or High Risk Myelofibrosis
HU-F-AIM - A prospective, interventional clinical study to evaluate hydroxyurea (HU) resistance in patients with polycythaemia vera who meet … Ended

2022-502338-20-00 6 2023-07-28 Polycythemia vera
Escalated single Platelet Inhibition for one month plus Direct oral anticoagulation in patients with Atrial fibrillation and acUte coRonary … Ended

2024-512727-36-00 6 2021-12-21 Patients with atrial fibrillation and ST-segment elevation myocardial

Showing 1–4 of 4 trials